C A P S Pharmacy
C A P S Pharmacy (Central Admixture Pharmacy Services, Inc.) is a U.S. sterile injectable compounder and subsidiary of B. Braun Medical Inc., operating the nation's largest network of outsourcing admixture pharmacies. It delivers customized 503A compounded sterile preparations, primarily parenteral nutrition and ready-to-use IV products, to hospitals and outpatient providers across 21 U.S. locations.
- Company typePrivate
- Founded1991
- HeadquartersAllentown, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What C A P S Pharmacy does
C A P S Pharmacy (Central Admixture Pharmacy Services, Inc.) is a U.S. sterile injectable compounding company founded in 1991 and operating as a subsidiary of B. Braun Medical Inc. within the B. Braun Group of Companies. It runs the nation's largest network of outsourcing admixture pharmacies, comprising 21 state-licensed 503A regional pharmacies and (as of recent disclosure) two FDA-registered 503B outsourcing facilities in Lehigh Valley, Pennsylvania and Phoenix, Arizona. In 2025, CAPS announced a strategic exit from the 503B business to refocus on its core 503A compounding operations, with a 90-day transition period for 503B customers.
The company's core products include custom patient-specific parenteral nutrition (PN) solutions, cardioplegia solutions for cardiac surgery, pre-filled anesthesia syringes, and a standardized drug delivery portfolio of premixed IV solutions such as Oxytocin, Magnesium Sulfate, Vancomycin, and Norepinephrine. Compounding operations run in USP <797>-compliant ISO Class 5 cleanrooms within ISO Class 7 buffer zones, with 503B facilities additionally operating under cGMP with the proprietary Test, Hold and Release (THR) program providing 100% sterility, endotoxin, and potency release testing using BacT/ALERT microbial detection. Supporting technology includes the proprietary CAPSLink online ordering portal with EHR PDF integration and a calcium-phosphate solubility curve screening window for PN formulations, barcoded manual-add safety checks, and an integration with Kit Check for RFID-tagged pre-filled syringes.
CAPS generates revenue through enterprise contracts with U.S. hospitals, outpatient facilities, and home infusion providers via recurring daily delivery of patient-specific sterile preparations (503A), transaction-based batch anticipatory compounding (503B, now being wound down), professional consulting services through CAPS Consulting and ReadyCheck 797/800 assessments, and PN clinical training programs. Pricing is quote-based and not publicly disclosed, with a national Premier Inc. group purchasing agreement (January 2019) anchoring enterprise access. The company goes to market through direct enterprise field sales, healthcare industry tradeshows (ASHP, AmSECT, NHIA), and content marketing via the CAPS Compounding Insights newsletter and podcast, with daily direct delivery plus same-day and next-day options serving as the core distribution model.
C A P S Pharmacy firmographics
Firmographics- Name
- C A P S Pharmacy
- Legal name
- Central Admixture Pharmacy Services, Inc.
- Website
- https://capspharmacy.com
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- C A P S Pharmacy (Central Admixture Pharmacy Services, Inc.) is a U.S. sterile injectable compounder and subsidiary of B. Braun Medical Inc., operating the nation's largest network of outsourcing admixture pharmacies. It delivers customized 503A compounded sterile preparations, primarily parenteral nutrition and ready-to-use IV products, to hospitals and outpatient providers across 21 U.S. locations.
- Ownership category
- akta.pro rank
C A P S Pharmacy industry classification
Industry- Product category
- Compounding Pharmacy Services
- NAICS
- Pharmacies and Drug Retailers (456110)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Hospital & Health-System Pharmacies (Inpatient/Outpatient) (HLAFALAB)
- akta.pro secondary industries
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC)
Keywords
Where C A P S Pharmacy is headquartered
LocationHeadquarters
- HQ city
- Allentown
- HQ country
- United States
- HQ region
- North America
Offices24 records
Markets served
C A P S Pharmacy business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- 503A Patient-Specific Compounding Services: Customized, patient-specific compounded sterile preparations dispensed upon receipt of a prescription. Services include parenteral nutrition (PN), patient-specific drug doses, IVPB, and syringes. Delivered daily from 21 regional pharmacies to hospital and outpatient pharmacy customers.
- 503B Batch Compounding Services: Non-patient-specific, anticipatory batch compounding under cGMP regulations including 100% release testing. Products include cardioplegia, anesthesia syringes, standardized drug delivery, and neonatal PN starter bags.
- CAPS Consulting Services: Professional consulting services for sterile compounding compliance including ReadyCheck 797, ReadyCheck 800 assessments, USP compliance, and remediation projects.
- PN Clinical Training Services: Web-based training program for pharmacists and clinicians on parenteral nutrition including patient identification, PN formulation design, and patient monitoring.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
C A P S Pharmacy product offering
Product offeringCore offering
CAPS (Central Admixture Pharmacy Services, Inc.) is the nation's largest network of outsourcing admixture pharmacies, providing customized, patient-specific compounded sterile preparations (503A) such as parenteral nutrition, cardioplegia solutions, pre-filled anesthesia syringes, and standardized premixed drug delivery to hospital pharmacies and outpatient facilities. The company supports customers with the proprietary CAPSLink ordering platform, daily direct delivery from 21 regional pharmacies, and complementary sterile compounding consulting and parenteral nutrition clinical training services.
Product overview
CAPS (Central Admixture Pharmacy Services) is the nation's largest network of outsourcing admixture pharmacies offering a portfolio of sterile compounding products and services. The core offerings include custom patient-specific Parenteral Nutrition (PN), Cardioplegia solutions for cardiac surgery, Pre-filled Anesthesia Syringes, and Standardized Drug Delivery (premixed IV solutions). These products are supported by the proprietary CAPSLink ordering platform and complemented by CAPS Consulting services (including ReadyCheck 797/800 compliance assessments) and PN Clinical Training Services. CAPS operates under both 503A (patient-specific) and 503B (batch/outsourcing) regulatory frameworks with 21 regional 503A pharmacies and 2 FDA-registered 503B outsourcing facilities. The company also offers the Test, Hold and Release (THR) quality assurance program for batch release testing.
Differentiator
Problem solved
Functional benefit
Brands
- Test, Hold and Release (THR): CAPS' quality assurance program implementing cGMP level release testing standards for 503B facilities engaged in anticipatory compounding.
- CAPS Consulting
- ReadyCheck
- CAPS Compounding Insights
- CAPSLink
- CAPS PN Clinical Training Services
Products and services
- Parenteral Nutrition (PN) Custom, patient-specific parenteral nutrition solutions designed to meet unique nutritional needs of individual patients, compounded daily at 503A regional pharmacies and delivered to hospital and outpatient pharmacy customers.
- Cardioplegia Solutions Cardioplegia solutions for cardiac surgery, including Blood Cardioplegia Formulas, Crystalloid Cardioplegia Formulas, del Nido formula, and Microplegia, with batch level release testing and extended beyond use dating for hospital cardiac surgery teams.
- Pre-filled Anesthesia Syringes Pre-filled, labeled anesthesia syringes available in frequently used drug concentrations and fill volumes with ASTM color-coded labels, tamper-evident caps, and 90-day extended beyond-use dating. Includes Atropine, Bupivacaine, Ephedrine, Fentanyl, Glycopyrrolate, Ketamine, Lidocaine, Neostigmine, Phenylephrine, Rocuronium, Vecuronium, and Succinylcholine.
- Standardized Drug Delivery Ready-to-use premixed drug services and compounded sterile preparations with validated, extended beyond-use dating for labor and delivery, critical care, antibiotics, and other hospital use cases, including Oxytocin, Magnesium Sulfate, Calcium Gluconate, Potassium Phosphate, Vancomycin, Diltiazem, Epinephrine, Norepinephrine, Phenylephrine, and Tromethamine.
- CAPSLink Online Ordering Portal Proprietary web-based online ordering portal that enables secure ordering with built-in safety checks, EHR PDF integration, a calcium-phosphate solubility curve window for PN formulation screening, and no equipment installation required.
- CAPS Consulting Services Sterile compounding consulting services including ReadyCheck 797 and ReadyCheck 800 compliance assessments, USP <797>, USP <800>, and 503B outsourcing compliance work, supported by over 25 years of CAPS pharmacy and clean-room experience.
- CAPS PN Clinical Training Services Web-based training program for pharmacists and clinicians to identify patients appropriate for parenteral nutrition, design PN formulations, monitor patients for tolerance, and understand PN complications, supplemented by clinical liaison services.
Quantifiable outcome
- Hospitals can redeploy pharmacist labor from compounding to clinical activities such as managing patient outcomes and pharmaceutical care interventions
Companies that use C A P S Pharmacy
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
C A P S Pharmacy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature4 records
C A P S Pharmacy partnerships and signals
Strategic signalScale indicators7 records
Recent moves7 records
Expansion highlights4 records
C A P S Pharmacy competitors and assessment
Company assessmentDirect peers
- QuVa Pharma: QuVa is one of the largest US 503B outsourcing sterile compounding pharmacies, competing head-to-head with CAPS on batch-prepared anesthesia syringes, cardioplegia, and standardized IV admixtures for hospital systems. Direct competitor in both products and customer base.
- Pharmedium Services (B. Braun): Pharmedium, acquired by B. Braun in 2015, operates the largest 503B outsourcing network in the US for sterile preparations and IV admixtures. Sister company to CAPS within the B. Braun portfolio with overlapping 503B batch compounding services.
- JCB Labs (Wells Pharma): JCB Labs is an FDA-registered 503B outsourcing sterile compounding pharmacy serving hospital and outpatient customers with prefilled syringes and batched CSPs. Direct 503B peer competing for similar hospital pharmacy contracts.
- Leiters Health: Leiters is an FDA-registered 503B outsourcing facility specializing in sterile admixture services for hospitals and health systems, including pre-filled syringes and ready-to-administer preparations. Direct 503B competitor to CAPS, particularly post-CAPS 503B wind-down.
- Olympia Pharmaceuticals: Olympia operates an FDA-registered 503B outsourcing facility providing sterile admixture services, pre-filled syringes, and batch-compounded sterile preparations to hospital pharmacies nationally. Direct competitor in the 503B outsourcing segment CAPS is exiting.
Broad incumbents
- Baxter International: Baxter is a global manufacturer of IV solutions, premixed drugs, and hospital pharmacy products - including large-volume parenterals that overlap with CAPS' Standardized Drug Delivery offerings. Broad incumbent in hospital pharmacy supply with comparable customer relationships at acute-care hospitals.
- ICU Medical: ICU Medical manufactures IV therapy, infusion, and compounding-related products including ready-to-administer premixed IV solutions and closed-system transfer devices for hospital pharmacies. Broad incumbent adjacent to CAPS' premixed drug and anesthesia syringe categories.
- B. Braun Medical Inc. B. Braun Medical is CAPS' parent company and a global manufacturer of IV solutions, infusion pumps, and sterile compounding inputs (including the CAPS-served PN components). Owns Pharmedium as a sister 503B asset and is the ultimate strategic decision-maker for CAPS.
Others
- Omnicell: Omnicell provides hospital pharmacy automation, IV compounding workflow software, and medication management technology that complements or competes with outsourced sterile compounding services like CAPS. Adjacent ecosystem player in hospital pharmacy with comparable enterprise hospital sales motion.
Emerging players
- Revelation Pharma: Revelation Pharma operates a network of 503A and 503B compounding pharmacies across the US focused on sterile preparations for hospital and alternate-site customers. Emerging national platform competing with CAPS in outsourced sterile compounding.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
C A P S Pharmacy social profiles
Digital presenceC A P S Pharmacy compliance and trust
Trust signalCompliance10 records
C A P S Pharmacy financial estimates
Financial estimateRevenue estimate
Valuation estimate
C A P S Pharmacy leadership team
Management profileNumber of profiles
Profiles4 records
C A P S Pharmacy funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
C A P S Pharmacy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about C A P S Pharmacy
What does C A P S Pharmacy do?
CAPS (Central Admixture Pharmacy Services, Inc.) is the nation's largest network of outsourcing admixture pharmacies, providing customized, patient-specific compounded sterile preparations (503A) such as parenteral nutrition, cardioplegia solutions, pre-filled anesthesia syringes, and standardized premixed drug delivery to hospital pharmacies and outpatient facilities. The company supports customers with the proprietary CAPSLink ordering platform, daily direct delivery from 21 regional pharmacies, and complementary sterile compounding consulting and parenteral nutrition clinical training services.
Is C A P S Pharmacy a public or private company?
C A P S Pharmacy is a private company. It is classified as corporate owned and is currently operating.
When was C A P S Pharmacy founded?
C A P S Pharmacy was founded in 1991. It employs 501 to 1,000 people.
Where is C A P S Pharmacy based?
C A P S Pharmacy is headquartered in Allentown, United States, in the North America region.
How does C A P S Pharmacy make money?
Four revenue lines are on record. 503A Patient-Specific Compounding Services are the primary driver. The others are 503B Batch Compounding Services, CAPS Consulting Services and PN Clinical Training Services.
Who are C A P S Pharmacy's main competitors?
Direct peers on record are QuVa Pharma, Pharmedium Services (B. Braun), JCB Labs (Wells Pharma), Leiters Health and Olympia Pharmaceuticals. Broad incumbents are Baxter International, ICU Medical and B. Braun Medical Inc.. Omnicell is listed as an others. Revelation Pharma is listed as an emerging player.
Does C A P S Pharmacy have an API?
No public API is recorded for C A P S Pharmacy.
What industry is C A P S Pharmacy in?
C A P S Pharmacy's product category is Compounding Pharmacy Services. Its primary akta.pro industry code is HLAFALAB, Hospital & Health-System Pharmacies (Inpatient/Outpatient), with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 456110 and its SIC code is 8000.